Figure 4
From: Androgen receptor expression in metastatic adenocarcinoma in females favors a breast primary
Negative for Androgen receptors (40×). A. Lung carcinoma (Nuclei- non-immunoreactive, Cytoplasm- immunoreactive), B. Endometrial carcinoma (Both, nuclei and cytoplasm- non-immunoreactive), C. Pancreatic carcinoma (Both, nuclei and cytoplasm- non-immunoreactive).